Mayfair 101’s James Mawhinney has defeated bankruptcy action by the owner of marketing firm 360 Degree Media, who claimed the founder of the beleaguered wealth management business owed him $3.5 million.
The corporate regulator is on a winning streak in its greenwashing cases, with a judge rejecting Active Super’s attempt to qualify its “unequivocal” statements about limiting its investment in companies connected to gambling and coal mining.
The High Court has dismissed an appeal of a decision which found Indonesia’s national airline could avail itself of foreign state immunity to defeat a winding up application.
Unanimously dismissing an appeal by thoroughbred breeding and horseracing giant Godolphin, the High Court has ruled on the proper construction of a tax exemption for rural land in NSW.
The co-owners of Pacific Werribee shopping centre in Victoria have largely won their bid for insurance documents as they weigh a second case against collapsed construction company, allegedly worth up to $335 million.
A judge has excused cryptocurrency product provider Block Earner from paying a penalty in a case brought by ASIC, despite finding it provided a financial product without a licence, because it obtained legal advice and genuinely believed it was not breaching the law.
A judge has thrown out a self-represented customer’s lawsuit against non-bank lender Latitude Financial after he defaulted on court orders and refused to join tech giants DXC Technology and Crowdstrike to his case over a cyberattack that compromised 14 million customer records.
A judge has ordered Sydney coffee shop chain 85 Degrees to pay a $1.44 million penalty for underpayments by its franchisees, saying it cannot be seen as acceptable for franchisors to “turn a blind eye” to contraventions by franchisees.
Former radio host Antoinette Lattouf is planning to bring an unfair termination case against the broadcaster, after the Fair Work Commission found the ABC terminated her from a casual presenting role.
A judge has upheld Neurim Pharmaceutical’s claim for additional damages against two generic drug companies found to have infringed its patent for insomnia drug Circadin, despite the company’s failure to comply with an earlier ruling.